Literature DB >> 7891374

Genetic heterogeneity in hereditary haemorrhagic telangiectasia: possible correlation with clinical phenotype.

K A McAllister1, F Lennon, B Bowles-Biesecker, W C McKinnon, E A Helmbold, D S Markel, C E Jackson, A E Guttmacher, M A Pericak-Vance, D A Marchuk.   

Abstract

Hereditary haemorrhagic telangiectasia (HHT) or Osler-Weber-Rendu syndrome is an autosomal dominant vascular dysplasia characterised by recurrent haemorrhage. Our initial linkage studies found an HHT gene to be localised to 9q3 in two large kindreds. In the present study, we examine an additional five unrelated HHT families. Linkage analysis in this region resulted in a peak multipoint location score of 13.03, 10 cM proximal of D9S60. We found significant evidence for heterogeneity of HHT. Multipoint analysis supports the family specific two point studies with odds of 3,000,000:1 showing linkage and heterogeneity over linkage and homogeneity. Four of the seven families give a posterior probability of > 99% of being of the linked type, and three families appear unlinked to this region of 9q, and by multipoint analysis completely exclude the candidate region for HHT. Two new crossovers in affected persons in one of the linked families further define the proximal border of the candidate region on 9q3. A possible correlation in clinical phenotype between the 9q3 linked families and unlinked families is described. Although six of the seven families clearly meet the clinical criteria for HHT diagnosis, a significant absence of pulmonary arteriovenous malformations is seen in all three 9q3 unlinked families. Genetic heterogeneity of HHT and its potential correlation with a clinical phenotype may have a significant impact on the clinical management and treatment of HHT patients.

Entities:  

Mesh:

Year:  1994        PMID: 7891374      PMCID: PMC1016692          DOI: 10.1136/jmg.31.12.927

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  10 in total

1.  Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population.

Authors:  H Plauchu; J P de Chadarévian; A Bideau; J M Robert
Journal:  Am J Med Genet       Date:  1989-03

2.  Faster sequential genetic linkage computations.

Authors:  R W Cottingham; R M Idury; A A Schäffer
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

3.  Report and abstracts of the Second International Workshop on Human Chromosome 9 Mapping 1993.

Authors:  D J Kwiatkowski; J Armour; A E Bale; J W Fountain; D Goudie; J L Haines; M A Knowles; A Pilz; S Slaugenhaupt; S Povey
Journal:  Cytogenet Cell Genet       Date:  1993

4.  Clinical manifestations of hereditary hemorrhagic telangiectasia.

Authors:  P J Reilly; T T Nostrant
Journal:  Am J Gastroenterol       Date:  1984-05       Impact factor: 10.864

5.  A gene for hereditary haemorrhagic telangiectasia maps to chromosome 9q3.

Authors:  C L Shovlin; J M Hughes; E G Tuddenham; I Temperley; Y F Perembelon; J Scott; C E Seidman; J G Seidman
Journal:  Nat Genet       Date:  1994-02       Impact factor: 38.330

6.  A disease locus for hereditary haemorrhagic telangiectasia maps to chromosome 9q33-34.

Authors:  M T McDonald; K A Papenberg; S Ghosh; A A Glatfelter; B B Biesecker; E A Helmbold; D S Markel; A Zolotor; W C McKinnon; J L Vanderstoep
Journal:  Nat Genet       Date:  1994-02       Impact factor: 38.330

Review 7.  Clinical spectrum of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease).

Authors:  W H Peery
Journal:  Am J Med       Date:  1987-05       Impact factor: 4.965

8.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

9.  Hereditary haemorrhagic telangiectasia: a clinical analysis.

Authors:  M E Porteous; J Burn; S J Proctor
Journal:  J Med Genet       Date:  1992-08       Impact factor: 6.318

10.  Neurological manifestations of hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease): report of 2 cases and review of the literature.

Authors:  G Román; M Fisher; D P Perl; C M Poser
Journal:  Ann Neurol       Date:  1978-08       Impact factor: 10.422

  10 in total
  14 in total

Review 1.  Hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations: issues in clinical management and review of pathogenic mechanisms.

Authors:  C L Shovlin; M Letarte
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

2.  Percutaneous transluminal embolization with coils-treatment of pulmonary arteriovenous malformations.

Authors:  Xi Liu; Chengkai Zhou; Gansheng Feng; Caixia Kong
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2002

3.  Clinical heterogeneity in hereditary haemorrhagic telangiectasia: are pulmonary arteriovenous malformations more common in families linked to endoglin?

Authors:  J N Berg; A E Guttmacher; D A Marchuk; M E Porteous
Journal:  J Med Genet       Date:  1996-03       Impact factor: 6.318

4.  Three novel mutations in the activin receptor-like kinase 1 (ALK-1) gene in hereditary hemorrhagic telangiectasia type 2 in Brazilian patients.

Authors:  A M Assis; F F Costa; V R Arruda; J M Annichino-Bizzacchi; C S Bertuzzo
Journal:  J Hum Genet       Date:  2007-01-12       Impact factor: 3.172

5.  Gastric angiodysplasia in a hereditary hemorrhagic telangiectasia type 2 patient.

Authors:  Minsu Ha; Yoon Jae Kim; Kwang An Kwon; Ki Baik Hahm; Mi-Jung Kim; Dong Kyu Kim; Young Jae Lee; S Paul Oh
Journal:  World J Gastroenterol       Date:  2012-04-21       Impact factor: 5.742

6.  A murine model of hereditary hemorrhagic telangiectasia.

Authors:  A Bourdeau; D J Dumont; M Letarte
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

7.  The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2.

Authors:  J N Berg; C J Gallione; T T Stenzel; D W Johnson; W P Allen; C E Schwartz; C E Jackson; M E Porteous; D A Marchuk
Journal:  Am J Hum Genet       Date:  1997-07       Impact factor: 11.025

8.  Visceral manifestations in hereditary haemorrhagic telangiectasia type 2.

Authors:  S A Abdalla; U W Geisthoff; D Bonneau; H Plauchu; J McDonald; S Kennedy; M E Faughnan; M Letarte
Journal:  J Med Genet       Date:  2003-07       Impact factor: 6.318

9.  Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative.

Authors:  N Pece; S Vera; U Cymerman; R I White; J L Wrana; M Letarte
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

10.  Hereditary haemorrhagic telangiectasia with extensive liver involvement is not caused by either HHT1 or HHT2.

Authors:  M Piantanida; E Buscarini; C Dellavecchia; A Minelli; A Rossi; L Buscarini; C Danesino
Journal:  J Med Genet       Date:  1996-06       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.